CellgramⓇ Pipeline
Pharmicell has continued to study in order to launch new stem cell drugs, the only alternatives that can overcome the limits of treatment technologies for various kinds of incurable diseases.
Mesenchymal Stem Cell
Heart disease drug (HearticellgramⓇ_AMI)
Cardiac disease drug
Liver disease drug (Cellgram_LC)
hepatic insufficiency - Korea
hepatic insufficiency - USA
Others (Cellgram_ED)
impotence